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Abstract
Introduction:  Treatments  for  patients  with  laryngeal  cancer  often  have  an  impact  on  physical,
social, and  psychological  functions.
Objective:  To  evaluate  quality  of  life  and  voice  in  patients  treated  for  advanced  laryngeal
cancer through  surgery  or  exclusive  chemoradiation.
Methods:  Retrospective  cohort  study  with  30  patients  free  from  disease:  ten  total  laryngectomy
patients without  production  of  esophageal  speech  (ES);  ten  total  laryngectomy  patients  with
tracheoesophageal  speech  (TES),  and  ten  with  laryngeal  speech.  Quality  of  life  was  measured
by SF-36,  Voice-Related  Quality  of  Life  (V-RQOL),  and  Voice  Handicap  Index  (VHI)  protocols,
applied on  the  same  day.
Results:  The  SF-36  showed  that  patients  who  received  exclusive  chemoradiotherapy  had  better
quality of  life  than  the  TES  and  ES  groups.  The  V-RQOL  showed  that  the  voice-related  quality
of life  was  lower  in  the  ES  group.  In  the  VHI,  the  ES  group  showed  higher  scores  for  overall,
emotional,  functional,  and  organic  VHI.
Discussion:  Quality  of  life  and  voice  in  patients  treated  with  chemoradiotherapy  was  better
than in  patients  treated  surgically.
Conclusion:  The  type  of  medical  treatment  used  in  patients  with  laryngeal  cancer  can  bring
changes  in  quality  of  life  and  voice.
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Câncer  de  laringe:  qualidade  de  vida  e  voz  pós-tratamento
Resumo
Introduc¸ão:  Tratamentos  para  pacientes  com  câncer  de  laringe  podem  ter  grande  impacto  na
func¸ão física,  social  e  psicológica.
Objetivo:  Avaliar  qualidade  de  vida  e  voz  de  pacientes  tratados  de  câncer  avanc¸ado  de  laringe
por meio  cirúrgico  ou  quimioradioterapia  exclusiva.
Métodos:  Estudo  coorte  retrospectivo  com  30  pacientes  livres  da  doenc¸a:  sendo  10  laringec-
tomizados  totais  sem  produc¸ão  de  voz  esofágica  (SVE);  10  laringectomizados  totais  com  voz
traqueoesofágica  (VTE)  e  10  com  voz  laríngea.  A  qualidade  de  vida  foi  mensurada  pelos  proto-
colos SF-36;  Qualidade  de  Vida  em  Voz  (QVV)  e  Índice  de  Desvantagem  Vocal  (IDV),  aplicados
no mesmo  dia.
Resultados:  No  SF-36,  observou-se  que  pacientes  que  receberam  quimioradioterapia  exclusiva
apresentam  melhor  qualidade  de  vida  do  que  o  grupo  de  VTE  e  SVE.  No  QVV  observou-se  que
a qualidade  de  vida  relacionada  à  voz  é  menor  no  grupo  SVE.  No  IDV  grupo,  SVE  apresentou
escore maior  para  IDV  total,  emocional,  funcional  e  orgânica.
Discussão:  Qualidade  de  vida  e  voz  dos  pacientes  tratados  com  quimioradioterapia  é  melhor  do
que os  pacientes  tratados  cirurgicamente.
Conclusão:  O  tipo  de  tratamento  médico  utilizado  em  pacientes  com  câncer  de  laringe  pode
trazer alterac¸ões  na  qualidade  de  vida  e  voz.
© 2014  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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he  World  Health  Organization  deﬁnes  quality  of  life  as
omplete  physical,  social,  and  mental  well-being,  and  not
ust  absence  of  disease.1 The  voice,  as  a  major  vehicle  of
ommunication,  plays  a  key  role  in  the  quality  of  life  of
atients,  and  should  be  considered  as  an  indicator  of  health
r  disease.2
Treatments  for  patients  with  laryngeal  cancer  can  have
 major  impact  on  physical,  social,  and  psychological  func-
ion,  thus  altering  their  quality  of  life.3 To  know  the  impact
hat  treatment  can  have  on  quality  of  life  of  patients  with
aryngeal  cancer  is  of  utmost  importance  for  clinicians  and
esearchers  who  aim  not  only  to  cure  their  patients,  but  also
o  achieve  their  complete  well-being.
Laryngeal  cancer  is  one  of  the  most  common  types
o  affect  the  upper  airways.4 It  represents  25%  of  malig-
ant  tumors  of  the  head  and  neck,  and  affects  mainly
en.5 Although  survival  is  the  main  interest  concerning  the
atient’s  treatment,  other  parameters  such  as  quality  of
ife,  speech,  voice  function,  and  complications  of  treatment
re  important  when  therapies  are  compared,  such  as  surgery
nd  chemoradiation.6
Two  types  of  treatment  are  used  when  patients
re  diagnosed  with  advanced  laryngeal  cancer:  exclusive
hemoradiation  or  total  laryngectomy.  When  the  selected
ption  is  total  laryngectomy,  the  patient’s  voice  is  com-
letely  lost,  with  consequent  problems  in  communication
nd  personal  interactions.6
Communication  is  an  essential  part  of  social  life.7lthough  it  appears  that  patients  with  laryngeal  preser-
ation  have  better  quality  of  life,  the  toxic  effects  of
hemoradiation  and  scarring  after  treatments  can  lead  to
e
p
aoarseness,  dysphagia,  or  pain,  which  can  affect  quality  of
ife.8
Both  chemoradiation  and  total  laryngectomy  affect  qual-
ty  of  life,  although  in  different  ways.9 For  patients
ho  undergo  total  laryngectomy  as  treatment  modal-
ty,  there  are  three  possibilities  for  vocal  rehabilitation:
sophageal  speech  (ES),  tracheoesophageal  speech  (TES),
nd  electronic  larynx.  The  ﬁrst  two  are  the  most  often
sed.10 Patients  who  were  rehabilitated  with  tracheoe-
ophageal  prosthesis  have  a  signiﬁcantly  higher  speech
attern  when  compared  to  patients  who  used  other  methods
f  communication.11 Total  laryngectomy  brings  functional
imitations  to  the  individual,  and  these  do  not  necessarily
ranslate  into  poorer  quality  of  life.  In  a  survey  conducted
n  2010,  the  authors  observed  signiﬁcant  changes  in  speech
nd  deglutition  functions  in  patients  treated  for  laryngeal
ancer.5
Several  questionnaires  have  been  developed  to  assess
he  health  and  quality  of  life  of  patients  with  chronic
iseases,  and  may  be  used  in  patients  with  laryngeal
ancer.  These  questionnaires  have  been  used  in  previous
tudies,7,12--16 such  as:  SF-36  --  this  is  a  multidimensional
uestionnaire  consisting  of  36  items,  comprehending  eight
cales:  functional  capacity  (FC)  related  to  restrictions  to
aily  activities;  physical  aspect  (PA),  regarding  the  inﬂu-
nce  of  physical  limitations  in  daily  activities  or  work;  pain
P),  related  to  pain  and  its  inﬂuence  on  daily  life;  general
ealth  status  (GHS),  which  estimates  the  general  health  and
elf-expectations  about  the  future  development  of  health;
itality  (V),  related  to  the  feeling  of  being  full  of  energy  or
xhausted;  social  aspects  (SA),  related  to  the  inﬂuence  of
hysical  or  mental  limitations  in  social  activities;  emotional
spects  (EA),  assessing  the  inﬂuence  of  emotional  problems
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in  daily  activities  or  work;  and  mental  health  (MH),  on  the
general  mental  health  status,  including  anxiety,  depression,
and  mood.  It  has  a  ﬁnal  score  ranging  from  0  to  100,  where
0  corresponds  to  the  worst  general  health  status  and  100
to  the  best  health  status.  This  questionnaire  has  been
translated  and  validated  for  Brazilian  Portuguese.17
Voice-related  Quality  of  Life  (V-RQOL)  --  the  V-RQOL  has
been  translated  and  validated  for  Brazilian  Portuguese.18
This  questionnaire  contains  ten  questions  covering  two
domains:  social--emotional  and  physical  functioning.  The
score  for  each  question  ranges  from  1  to  5,  where  1  rep-
resents  ‘‘not  a  problem’’  and  5  ‘‘a  very  big  problem.’’
The  calculation  of  the  ﬁnal  score  is  made  based  on  the
rules  employed  in  several  questionnaires  on  quality  of  life.
A  standard  score  is  calculated  from  the  raw  score,  and  a
higher  value  indicates  that  the  quality  of  life  aspects  are  not
impaired  by  the  voice  functionality.  The  maximum  score  is
100  (best  quality  of  life),  and  the  minimum  score  is  0  (worst
quality  of  life),  both  for  a  particular  domain,  and  for  the
overall  score.
IDV  -- a protocol  that  evaluates  the  Voice  Handicap  Index
(VHI),  translated  and  validated  for  Brazilian  Portuguese  as
IDV.19 It  consists  of  30  items  that  assesses  three  areas:
functional,  organic,  and  emotional,  with  ten  items  each,
aimed  to  the  concept  of  disadvantage.  The  scores  are  cal-
culated  using  simple  summation,  and  may  vary  from  10
to  120;  the  higher  the  value,  the  greater  the  voice  hand-
icap.  Scores  from  0  to  30  are  considered  low,  indicating
that  there  is  a  probable  alteration  associated  with  voice
inadequacy;  31--60,  moderate  change  in  vocal  inadequacy;
61--120,  a  signiﬁcantly  severe  deterioration  of  a  voice  prob-
lem.
Thus,  the  aim  of  this  study  was  to  evaluate  quality  of  life
and  voice  of  patients  treated  for  advanced  laryngeal  cancer,
and  to  correlate  it  with  the  treatment  modalities  used  for
these  patients.
Materials and methods
Participants
This  study  was  submitted  and  approved  under  number
528/2011  by  the  institution’s  Research  Ethics  Committee.
Patient  recruitment  was  conducted  through  the  Hospital
Cancer  Registry.  The  data  collection  was  performed  from
January  of  2000  to  January  of  2008.  During  this  period,  257
patients  were  diagnosed  with  laryngeal  cancer.  The  inclusion
criteria  were:  patients  with  tumor  stage  T3  and  T4;  patients
treated  for  laryngeal  cancer;  with  no  associated  neurologi-
cal  alterations;  patients  without  evidence  of  disease  for  at
least  four  years.
Patients  with  metastases,  tumor  recurrence,  tumor  stage
T1  and  T2,  presence  of  residual  disease,  tracheostomy,  or
requiring  feeding  through  a  nasogastric  or  gastrostomy  tube
were  excluded  from  the  study.  Of  the  257  patients  with
laryngeal  tumors,  only  153  (59.53%)  had  tumor  stage  T3  and
T4.  Of  the  total  sample  of  T3  and  T4  stages,  only  73  (47.71%)
were  alive  at  the  time  of  the  study.  Patients  included  in  the
study  were  contacted  by  telephone  in  January  of  2012.
Of  the  73  patients  invited,  only  36  (49.31%)  agreed  to
participate.  In  order  to  have  groups  with  the  same  number
t
e
(405
f  patients,  the  ﬁrst  30  patients  who  answered  the  call  were
nrolled.  Of  these,  28  (80%)  were  men  and  two  (20%)  were
omen,  aged  between  45  and  85  years  (mean  65  years).
atients  were  grouped  by  type  of  treatment:  the  ﬁrst  group
G1)  consisted  of  ten  patients  submitted  to  total  laryngec-
omy  (six  with  radiotherapy  and  four  without  radiotherapy)
nd  who  communicated  by  writing  or  gestures;  the  sec-
nd  group  (G2)  consisted  of  ten  patients  submitted  to  total
aryngectomy  (ﬁve  with  radiotherapy  and  ﬁve  without  radio-
herapy)  and  who  used  tracheoesophageal  prosthesis;  the
hird  group  (G3)  consisted  of  ten  patients  who  were  treated
ith  exclusive  chemoradiation  and  had  preserved  larynx.
The  procedures  performed  were:  application  of  the  SF-36
rotocol  to  measure  quality  of  life  of  individuals;  application
f  the  VR-QOL  to  verify  the  quality  of  life  and  voice;  appli-
ation  of  the  VHI  to  assess  the  voice  handicap  index;  and
lso  vocal  self-evaluation  and  auditory  perception  analysis
f  individuals’  general  level  of  the  vocal  quality.
The  SF-36,  VR-QOL,  and  VHI  protocols  were  applied
n  the  same  day  in  all  participating  subjects.  Question-
aire  applications  and  voice  analyses  were  performed  by
our  speech  therapists  specialized  in  vocal  rehabilitation
f  patients  with  head  and  neck  malignancies.  Data  inter-
retation  was  performed  by  a  team  comprising  two  of  the
peech  therapists  and  two  otorhinolaryngologists  specialized
n  head  and  neck  surgery.
For  vocal  self-assessment,  subjects  were  instructed  to
ssess  what  they  thought  of  their  own  voice,  through  a
hree-point  scale:  (1)  good;  (2)  moderate;  and  (3)  poor.
t  the  auditory  perception  analysis  (APA),  the  individuals
ad  their  voices  recorded  in  a  laptop  (Samsung  Intel®
tomTM CPUN455@1.66Hz  1.67GHz),  using  the  software
oundForge® (Sony  Creative  Software  Inc.),  release  4.5.
ecordings  were  performed  with  a  headset  microphone
Bright®)  positioned  at  a  ﬁxed  distance  of  ﬁve  centimeters
rom  the  mouth,  in  an  acoustically  treated  room.  The  fol-
owing  samples  were  collected:  sustained  ‘‘A’’  vowel  and
ounting  numbers  from  1  to  10,  at  the  usual  frequency  and
ntensity.
The  auditory  perception  analysis  was  performed  by  four
peech  therapists,  who  were  aware  that  the  study  popula-
ion  consisted  of  individuals  treated  for  advanced  laryngeal
ancer,  but  were  unaware  of  the  treatment  option  used,  as
he  voices  were  recorded  and  they  did  not  have  eye  contact
ith  patients.  The  speech  therapists  were  instructed  to  clas-
ify  voices  through  a  three-point  scale  by  selecting  one  of
he  following  alternatives:  (1)  good;  (2)  moderate;  and  (3)
oor.  The  voices  were  recorded  and  then  played  through
peakers  in  an  acoustically  treated  room.
The  chi-squared  test  or  Fisher’s  exact  test  (for  expected
alues  <5)  were  used  to  compare  categorical  variables
etween  the  three  groups,  whereas  the  Kruskal--Wallis  test
as  used  to  compare  numerical  variables  between  the
hree  groups,  due  to  the  absence  of  normal  distribution
f  variables.  Concordance  analysis  of  the  assessment  of
atients’  voices  between  speech  therapists  was  assessed
ith  the  intraclass  correlation  coefﬁcient  (ICC).  The
ilcoxon’s  test  for  related  samples  was  used  to  compare
he  assessment  of  the  speech  therapists  and  patient’s  self-
valuation.The  signiﬁcance  level  for  statistical  tests  was  set  at  5%
p  <  0.05).
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Table  1  Comparison  of  the  items  of  the  SF-36  questionnaire  according  to  study  group.
G1  (no  voice)  G2  (TES)  G3  (laryngeal  voice)  pa
Age  65.8  65.10  61.60  0.534
Functional capacity  85.0  84.50  88.50  0.970
Physical aspects  65.0  100  77.50  0.100
Pain 68.6  81.80  90.10  0.035
Overall health  status  84.10  87.50  88.30  0.847
Vitality 90.0  81.50  74.50  0.054
Social aspects  95.0  100  83.50  0.152
Emotional aspects  63.33  93.33  80.0  0.230
Mental health 86.80 83.60 76.40 0.199
SF-36 questionnaire on quality of life, where a score closer to 100 indicates better quality of life and score closer to zero, poorer quality
of life; No voice, patients submitted to total laryngectomy, without voice; TES, patients submitted to total laryngectomy rehabilitated
with voice prosthesis, with tracheoesophageal speech.
a Kruskal--Wallis test.
Table  2  Comparative  statistical  analysis  of  the  QVV  questionnaire  items  according  to  the  study  group.
G1  (no  voice)  G2  (TES)  G3  (laryngeal  voice)  pa
Total  QVV  43.45  78.0  93.50  0.001
Total physical  48.13  84.38  96.25  0.031
Total emotional  41.63  73.73  90.83  0.001
QVV, quality of life and voice questionnaire, where scores close to 100 indicate better quality of life and voice; No voice, patients
submitted to total laryngectomy, without voice; TES, patients submitted to total laryngectomy, rehabilitated with voice prosthesis, with
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a Kruskal--Wallis test.
esults
he  overall  quality  of  life  of  patients  was  assessed  using
he  SF-36.  In  Table  1,  it  was  observed  that  all  groups  pre-
ented  changes  in  quality  of  life,  but  the  only  items  with
igniﬁcant  differences  were  pain  and  vitality.  G1  complained
ore  often  of  pain  than  G3,  which  had  a  score  closer  to  100.
egarding  vitality,  G3  complained  of  having  less  vitality.
The  results  of  SF-36  questionnaire  demonstrated  that
atients  treated  surgically  and  who  communicated  through
estures  or  writing  complained  more  often  of  pain  when
ompared  with  patients  with  tracheoesophageal  prosthe-
is  or  treated  exclusively  with  chemoradiation.  It  was  also
emonstrated  that  patients  with  total  laryngectomy  with
racheoesophageal  prosthesis  and  exclusive  chemoradiation
herapy  had  better  quality  of  life,  but  vitality  was  higher  in
1  (Table  1).
t
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Table  3  Comparative  statistical  analysis  of  the  VHI  questionnaire
G1  (no  voice)  G2
Total  handicap  40.30  10.
Emotional handicap  11.90  3.
Functional handicap  19.60  5.
Organic handicap 9.30  2.
VHI, voice handicap index, where scores closer to 100 indicate greater p
laryngectomy, without voice; TES, patients submitted to total laryngect
speech.
a Kruskal--Wallis test.Data  on  Table  2  demonstrates  that  patients  with  tra-
heoesophageal  prosthesis  had  better  quality  of  life  scores
hen  compared  with  G1  (without  vocal  rehabilitation),  but
orse  than  the  group  with  preserved  larynx.
In  Table  3,  regarding  the  VHI,  it  can  be  observed  that  the
1  (without  voice)  had  a  higher  score  in  all  items,  showing
hat  patients  with  no  voice  perceive  themselves  as  having
 major  vocal  disadvantage  compared  to  the  other  groups,
hile  patients  with  laryngeal  voice  had  the  lowest  scores  in
ll  items.
Table  4  presents  the  comparative  analysis  of  the  evalua-
ion  of  speech  therapists  and  patient  self-assessment.  There
as  a  signiﬁcant  difference  between  the  self-assessment  of
he  patient  and  that  made  by  speech  therapists  1,  3,  and
,  whose  mean  assessments  were  lower  than  patients’  self-
ssessment.  There  was  no  signiﬁcant  correlation  between
he  evaluations  of  the  four  speech  therapists  (ICC  =  0.108;
 items  according  to  the  study  group.
 (TES)  G3  (laryngeal  voice)  pa
80  4.90  0.001
40  0.80  0.001
20  2.10  0.001
20  1.40  0.002
erception of voice handicap; no voice, patients submitted to total
omy, rehabilitated with voice prosthesis, with tracheoesophageal
Larynx  cancer:  quality  of  life  and  voice  after  treatment  
Table  4  Comparative  statistical  analysis  between  speech
therapists  and  patient.
n  Mean  pa
Self-assessment  20  1.95  --
ST 1  20  1.55  0.021
ST 2  20  1.95  1.000
ST 3  20  1.50  0.003
ST 4  20  1.50  0.003
Mean STs  --  1.62  --
ST, speech therapist.
The mean assessment by STs 1, 3, and 4 was lower than patients’
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a Wilcoxon test.
95%  CI:  −0.066  to  0.373;  p  =  0.127).  There  was  no  signiﬁcant
agreement  between  examiners.
Patients  treated  with  exclusive  chemoradiation  therapy
presented  similar  results  to  patients  with  tracheoesophageal
prosthesis  at  the  self-assessment  (p  =  1.000).
Discussion
It  is  difﬁcult  to  assess  quality  of  life  and  voice  of  patients
treated  for  advanced  laryngeal  cancer,  assessing  the  medi-
cal,  psychological,  and  social  impact  on  the  life  of  each
patient  is  difﬁcult,  but  it  is  essential  in  order  to  establish
parameters  of  rehabilitation  and  support.5
The  SF-36  is  one  of  the  most  popular  tools  to  assess  qual-
ity  of  life  in  cancer  patients,  due  to  its  high  speciﬁcity  and
reliability.17
The  results  of  the  present  study  support  previous  ﬁndings
that  the  quality  of  life  of  patients  after  total  laryngectomy
for  laryngeal  cancer  submitted  to  vocal  rehabilitation  with
tracheoesophageal  prosthesis  may  be  similar  to  the  qual-
ity  of  life  of  patients  who  received  chemoradiation  therapy,
despite  the  different  qualities  of  voice.  In  these  patients,
not  only  the  treatment  choice  is  relevant  for  a  good  qual-
ity  of  life,  but  also  the  method  of  voice  rehabilitation  after
surgery.6 Thus,  it  was  observed  that  quality  of  life  of  patients
with  tracheoesophageal  voice  was  closer  to  the  quality
of  life  of  patients  who  received  exclusive  chemoradiation
therapy,  whereas  patients  submitted  to  total  laryngectomy
without  vocal  rehabilitation  had  worse  quality  of  life.  This
ﬁnding  is  corroborated  by  the  study  of  Clements  et  al.,  which
observed  a  worse  quality  of  life  in  total  laryngectomized
patients  who  communicated  through  gestures.3 Success-
ful  speech  rehabilitation  with  tracheoesophageal  prosthesis
after  total  laryngectomy  can  be  as  effective  as  treatment
with  chemoradiation  therapy  for  laryngeal  cancer,  regarding
psychosocial  reintegration  and  functional  ability.20
Therefore,  as  demonstrated  in  the  study  by  Giordano
et  al.,  patients  with  tracheoesophageal  prosthesis  had  bet-
ter  quality  of  life  when  compared  with  G1  (without  vocal
rehabilitation),  but  worse  when  compared  with  the  group
with  preserved  larynx.In  agreement  with  the  study  by  Schuster  et  al.,  it
was  observed  that  patients  with  tracheoesophageal  speech
appreciated  their  new  method  of  communication,  but  not  as
much  as  patients  with  a  preserved  larynx.7 Terrell  et  al.  also
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eported  that  patients  who  underwent  exclusive  chemoradi-
tion  tended  to  have  better  quality  of  life,  with  better  scores
t  the  SF-36,  when  compared  with  patients  who  underwent
otal  laryngectomy.8
When  the  patients’  self-assessment  is  compared  with  the
valuation  made  by  speech  therapists,  it  can  be  observed
hat  speech  therapists  found  the  voice  of  patients  with
racheoesophageal  speech  (Table  4)  to  be  the  worst,  per-
aps  due  to  a  more  critical  sense  regarding  voice  quality,
s  the  self-assessment  of  patients  in  both  groups  was  simi-
ar.  These  ﬁndings  are  different  from  those  in  the  study  by
inizia  et  al.,  which  found  a  signiﬁcant  difference  in  the
elf-assessment  of  patients,  where  total  laryngectomized
atients  with  tracheoesophageal  prosthesis  evaluated  their
oices  as  being  worse  than  patients  with  preserved  larynx.4
Regarding  quality  of  life  and  voice,  the  results  indicate
hat  not  only  the  method  of  treatment  used  is  important
total  laryngectomy  vs.  chemoradiation),  as  well  as  the
resence  of  vocal  rehabilitation  after  total  laryngectomy,
s  there  was  a  signiﬁcant  difference  between  G1  and  G2.
lthough  patients  in  both  G2  and  G3  had  a  functioning
oice,  there  was  no  signiﬁcant  difference  in  vocal  quality.
2,  whose  patients  use  a tracheoesophageal  prosthesis  as
 method  of  communication,  has  worse  voice-related  qual-
ty  of  life  when  compared  to  patients  from  G3,  who  had
he  larynx  preserved,  showing  that  the  natural  larynx  is
rreplaceable.
This  ﬁnding  differs  from  those  by  Finizia  et  al.,  who
eported  that  the  quality  of  life  of  patients  with  tracheoe-
ophageal  prosthesis  was  better  than  that  of  patients  who
eceived  radiotherapy  alone,  but  it  is  similar  to  the  results  of
he  studies  by  Oridate  et  al.  and  by  Boscolo-Rizzo  et  al.6,21,22
n  the  study  by  Terrel  et  al.,  all  patients  submitted  to  total
aryngectomy  had,  in  the  long-term,  considerable  time  to
eadjust  to  their  new  condition,  and  therefore  their  scores
ould  be  higher,  as  they  were  less  worried  about  difﬁcul-
ies  with  volume,  clarity,  and  overall  ability  to  speak.8 It
s  believed  that  this  is  due  to  the  fact  that  patients  sub-
itted  to  total  laryngectomy,  as  they  lived  for  some  time
ithout  voice,  lost  their  auditory  memory;  when  they  have
he  opportunity  of  communication,  the  acquired  voice  is
erceived  by  them  as  excellent.
Patients  who  received  exclusive  chemoradiation  therapy,
s  they  are  aware  of  their  pretreatment  voices,  classify
heir  post-treatment  voices  as  moderate  when  compared  to
he  pre-treatment.  Studies  demonstrate  that  patients  who
nderwent  total  laryngectomy  are  more  concerned  with  the
hysical  consequences  of  surgery  and  interference  in  social
ctivities  than  with  impaired  communication.23 In  the  imme-
iate  postoperative  period,  patients  already  show  functional
imitations.  However,  subsequently,  when  the  fear  of  death
nd  the  uncertainty  of  cure  have  been  overcome,  individuals
egin  to  observe  and  assess  the  functional  limitations  result-
ng  from  their  treatment  by  assigning  positive  and  negative
oints  that  will  directly  inﬂuence  their  quality  of  life.
According  to  Gomes  and  Rodrigues  et  al.,  total  laryngec-
omized  patients  with  tracheoesophageal  prosthesis  have
etter  quality  of  life  as,  unlike  patients  with  exclusive
hemoradiation  therapy,  they  undergo  speech  therapy;  this
lose  contact  with  the  therapist  can  bring  a positive  inﬂu-
nce  to  the  patient’s  vocal  perception.5 Robertson  reported
hat  patients  on  chemoradiation  therapy  often  do  not
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208  
ndergo  speech  and  deglutition  therapy,  and  that  this  can
mpair  their  quality  of  life,  when  compared  with  total  laryn-
ectomized  patients.24
When  comparing  the  self-assessment  of  patients  treated
olely  with  chemoradiotherapy,  with  total  laryngectomy  and
racheoesophageal  prosthesis,  the  present  study  observed  a
ifferent  result  that  by  Finizia  et  al.,6 who  reported  that  the
ocal  quality  of  chemoradiation  therapy  is  better  assessed
y  patients  than  total  laryngectomized  patients.  Another
mportant  quality  of  life  factor  is  the  aspect  of  being  disease-
ree,  as  its  presence  inﬂuences  the  quality  of  life  due  to
hysical,  social,  and  psychological  negative  impacts  that
reatment  failure  brings  to  the  patient.  If  a  group  of  total
aryngectomized  patients  without  voice,  with  voice,  and
reserved  larynx,  but  with  persistent  had  been  assessed,
erhaps  their  quality  of  life  would  be  worse  than  in  the
hree  groups  without  the  disease.  Therefore,  the  cure  of
he  disease  itself  must  also  be  considered  in  the  quality  of
ife  assessment.
onclusion
egarding  quality  of  life  and  voice  of  the  patients  treated
or  advanced  laryngeal  cancer  and  currently  disease-free,  it
an  be  concluded  that:
.  Among  those  submitted  to  total  laryngectomy,  patients
with  tracheoesophageal  prosthesis  have  better  quality  of
life  and  voice.
.  Vocal  self-assessment  is  similar  among  patients  under-
going  chemoradiation  therapy  and  patients  with  tra-
cheoesophageal  prosthesis.  However,  in  the  audiological
assessment,  the  tracheoesophageal  voice  has  the  worst
performance.
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